Focus on neuroendocrine tumours
01 November 2023
It was a full house at Peter Mac this week for the 2023 NET Preceptorship, discussing the optimal management of patients with neuroendocrine tumours.
The meeting was organised by the Neuroendocrine Tumour (NET) Service - a multidisciplinary team of NET experts from Peter Mac and the Royal Melbourne Hospital.
Speakers addressed patient management from diagnosis, pathology, imaging, surgery, medical therapy (oncology, endocrinology, nuclear medicine) and nursing perspectives.
“Major themes of this meeting include how treatment varies based on disease biology and extent, and the importance of having a multidisciplinary management plan for these patients,” says Associate Professor Grace Kong who co-chairs the NET Service along with Prof Michael Michael, and who both spoke at the Preceptorship.
“This was the fifth NET preceptorship and we are delighted to see growing interest, with around 40 specialists from diverse fields attending this meeting.”
Neuroendocrine tumours are a wide-ranging group of rare tumours that develop from neuroendocrine cells. They can occur anywhere in the body but common sites are the small intestine, pancreas, lungs, appendix and rectum.
The NET Service was the first outside of Europe to be granted “Neuroendocrine Cancer Centre of Excellence” status from the European Neuroendocrine Tumour Society.
As a leader in the southern hemisphere, the NET Service consults on over 150 new NET patients each year from across Australia, New Zealand and South-East Asia.
Other Preceptorship speakers were Drs HuiLi Wong, Louise Jackett, Javad Saghebi, Rajeev Ravi, Lewis Au and Emma Boehm, Assoc Profs Cherie Chiang, Alison Trainer and Ben Loveday, Dietician Erin Liang and NET nurse consultant Kate Wakelin.
